EU AI Act Guide

EU AI Act for medical AI tools

Medical AI tools should be reviewed by clinical relevance, intended purpose, user context, patient impact, oversight model and evidence needs. The first step is diagnostic triage, not generic documentation.

Operational information, not legal advice.

Sector risk model

EU AI Act for Medical AI Tools

01

Sector context

Identify the sector logic around people, access, safety, finance, care or essential services.

02

Impact group

Clarify which customers, patients, learners, workers, applicants or citizens may be affected.

03

Decision pressure

Check whether the AI output can influence ranking, access, pricing, diagnosis, treatment or opportunity.

04

Sector control

Map the oversight, documentation, validation and review controls needed for the sector.

Strategic answer

Medical AI tools need review around intended purpose and clinical relevance.

Medical AI tools can support diagnosis, triage, documentation, prioritization or clinical workflows. Readiness depends on intended purpose, user context, patient impact, oversight and evidence, not only on whether a model is used.

Start with the EU AI Act Diagnostic, turn findings into an implementation plan, and see how the diagnostic works as a reference app on M13.

Exposure focus

What medical AI tool teams should review

  • Intended purpose and clinical or operational workflow.
  • User group, patient impact and decision relevance.
  • Data sensitivity and output dependency.
  • Human review, validation and monitoring evidence.

First action

What to do first

  1. 01Clarify intended purpose and user context.
  2. 02Map clinical relevance and patient impact.
  3. 03Review oversight and evidence gaps.
  4. 04Prioritize systems needing deeper readiness work.

This page provides operational information for AI governance readiness. It is not legal advice.